These findings may have application in vivo as tumors confer radioresistance in part by expression of angiogenic growth factors such as bFGF and VEGF, induced by hypoxia and HIF-1, that render protection to tumor endothelium [24]. The gene discussed is FGF2; the disease is neoplasm.